126 related articles for article (PubMed ID: 1558466)
1. Clinical experiments in maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia.
Mavissakalian M; Perel JM
Arch Gen Psychiatry; 1992 Apr; 49(4):318-23. PubMed ID: 1558466
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of imipramine maintenance treatment in panic disorder with agoraphobia.
Mavissakalian M; Perel JM
Am J Psychiatry; 1992 Aug; 149(8):1053-7. PubMed ID: 1636805
[TBL] [Abstract][Full Text] [Related]
3. Long-term maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia.
Mavissakalian MR; Perel JM
Arch Gen Psychiatry; 1999 Sep; 56(9):821-7. PubMed ID: 12884888
[TBL] [Abstract][Full Text] [Related]
4. Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine.
Schweizer E; Rickels K; Weiss S; Zavodnick S
Arch Gen Psychiatry; 1993 Jan; 50(1):51-60. PubMed ID: 8422222
[TBL] [Abstract][Full Text] [Related]
5. Duration of imipramine therapy and relapse in panic disorder with agoraphobia.
Mavissakalian MR; Perel JM
J Clin Psychopharmacol; 2002 Jun; 22(3):294-9. PubMed ID: 12006900
[TBL] [Abstract][Full Text] [Related]
6. Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships.
Mavissakalian MR; Perel JM
Am J Psychiatry; 1995 May; 152(5):673-82. PubMed ID: 7726306
[TBL] [Abstract][Full Text] [Related]
7. 2nd year maintenance and discontinuation of imipramine in panic disorder with agoraphobia.
Mavissakalian MR; Perel JM
Ann Clin Psychiatry; 2001 Jun; 13(2):63-7. PubMed ID: 11534926
[TBL] [Abstract][Full Text] [Related]
8. Specific side effects of long-term imipramine management of panic disorder.
Mavissakalian M; Perel J; Guo S
J Clin Psychopharmacol; 2002 Apr; 22(2):155-61. PubMed ID: 11910260
[TBL] [Abstract][Full Text] [Related]
9. Gauging the effectiveness of extended imipramine treatment for panic disorder with agoraphobia.
Mavissakalian MR; Perel JM; Talbott-Green M; Sloan C
Biol Psychiatry; 1998 Jun; 43(11):848-54. PubMed ID: 9611676
[TBL] [Abstract][Full Text] [Related]
10. Imipramine treatment of panic disorder with agoraphobia: the second time around.
Mavissakalian MR; Perel JM; de Groot C
J Psychiatr Res; 1993; 27(1):61-8. PubMed ID: 8515390
[TBL] [Abstract][Full Text] [Related]
11. Maintenance drug therapy of panic disorder.
Curtis GC; Massana J; Udina C; Ayuso JL; Cassano GB; Perugi G
J Psychiatr Res; 1993; 27 Suppl 1():127-42. PubMed ID: 8145175
[TBL] [Abstract][Full Text] [Related]
12. Imipramine in the treatment of agoraphobia: dose-response relationships.
Mavissakalian M; Perel J
Am J Psychiatry; 1985 Sep; 142(9):1032-6. PubMed ID: 3895987
[TBL] [Abstract][Full Text] [Related]
13. Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper.
Rickels K; Schweizer E; Weiss S; Zavodnick S
Arch Gen Psychiatry; 1993 Jan; 50(1):61-8. PubMed ID: 8422223
[TBL] [Abstract][Full Text] [Related]
14. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia.
Bakish D; Hooper CL; Filteau MJ; Charbonneau Y; Fraser G; West DL; Thibaudeau C; Raine D
Psychopharmacol Bull; 1996; 32(1):135-41. PubMed ID: 8927663
[TBL] [Abstract][Full Text] [Related]
15. The side effects burden of extended imipramine treatment of panic disorder.
Mavissakalian MR; Perel JM
J Clin Psychopharmacol; 2000 Oct; 20(5):547-55. PubMed ID: 11001240
[TBL] [Abstract][Full Text] [Related]
16. Effect of imipramine treatment on heart rate variability measures.
Yeragani VK; Pohl R; Balon R; Ramesh C; Glitz D; Weinberg P; Merlos B
Neuropsychobiology; 1992; 26(1-2):27-32. PubMed ID: 1475036
[TBL] [Abstract][Full Text] [Related]
17. Imipramine dose-response relationship in panic disorder with agoraphobia. Preliminary findings.
Mavissakalian MR; Perel JM
Arch Gen Psychiatry; 1989 Feb; 46(2):127-31. PubMed ID: 2643933
[TBL] [Abstract][Full Text] [Related]
18. Three-year follow-up of patients with panic disorder after short-term treatment with alprazolam and imipramine.
Lepola UM; Rimón RH; Riekkinen PJ
Int Clin Psychopharmacol; 1993; 8(2):115-8. PubMed ID: 8345160
[TBL] [Abstract][Full Text] [Related]
19. Treatment of panic disorder.
Cassano GB; Toni C; Musetti L
Adv Biochem Psychopharmacol; 1992; 47():449-60. PubMed ID: 1509926
[No Abstract] [Full Text] [Related]
20. Alprazolam plasma concentrations and treatment response in panic disorder and agoraphobia.
Lesser IM; Lydiard RB; Antal E; Rubin RT; Ballenger JC; DuPont R
Am J Psychiatry; 1992 Nov; 149(11):1556-62. PubMed ID: 1415824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
